Prestige Consumer Healthcare Inc
NYSE:PBH

Watchlist Manager
Prestige Consumer Healthcare Inc Logo
Prestige Consumer Healthcare Inc
NYSE:PBH
Watchlist
Price: 84.85 USD 0.84% Market Closed
Market Cap: 4.2B USD
Have any thoughts about
Prestige Consumer Healthcare Inc?
Write Note

Relative Value

The Relative Value of one PBH stock under the Base Case scenario is 84.32 USD. Compared to the current market price of 84.85 USD, Prestige Consumer Healthcare Inc is Overvalued by 1%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PBH Relative Value
Base Case
84.32 USD
Overvaluation 1%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
37
Median 3Y
2.8
Median 5Y
2.6
Industry
2.5
Forward
3.7
vs History
0
vs Industry
28
Median 3Y
14.6
Median 5Y
13.1
Industry
21.9
Forward
19
vs History
0
vs Industry
29
Median 3Y
12.9
Median 5Y
11.7
Industry
16.5
vs History
vs Industry
19
Median 3Y
12.2
Median 5Y
-21.1
Industry
23.6
vs History
0
vs Industry
37
Median 3Y
2
Median 5Y
1.9
Industry
2.1
vs History
1
vs Industry
28
Median 3Y
4
Median 5Y
3.9
Industry
2.6
Forward
4.5
vs History
0
vs Industry
28
Median 3Y
7.2
Median 5Y
6.8
Industry
5.2
vs History
14
vs Industry
30
Median 3Y
12.6
Median 5Y
12
Industry
13.3
Forward
13.8
vs History
0
vs Industry
31
Median 3Y
12.9
Median 5Y
12.5
Industry
16.6
Forward
15.1
vs History
14
vs Industry
23
Median 3Y
18
Median 5Y
17.6
Industry
15.6
vs History
17
vs Industry
21
Median 3Y
18.7
Median 5Y
18.5
Industry
19.1
vs History
0
vs Industry
47
Median 3Y
1.3
Median 5Y
1.2
Industry
1.9

Multiples Across Competitors

PBH Competitors Multiples
Prestige Consumer Healthcare Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Prestige Consumer Healthcare Inc
NYSE:PBH
4.2B USD 3.8 20.4 14.6 16
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top